[go: up one dir, main page]

CU20110104A7 - Dos tipos de formas cristalinas de pinocembrina, su preparación y su uso para fabricar composiciones farmacéuticas - Google Patents

Dos tipos de formas cristalinas de pinocembrina, su preparación y su uso para fabricar composiciones farmacéuticas

Info

Publication number
CU20110104A7
CU20110104A7 CU20110104A CU20110104A CU20110104A7 CU 20110104 A7 CU20110104 A7 CU 20110104A7 CU 20110104 A CU20110104 A CU 20110104A CU 20110104 A CU20110104 A CU 20110104A CU 20110104 A7 CU20110104 A7 CU 20110104A7
Authority
CU
Cuba
Prior art keywords
preparation
pharmaceutical compositions
pinocembrine
types
crystal forms
Prior art date
Application number
CU20110104A
Other languages
English (en)
Other versions
CU24127B1 (es
Inventor
Zhihong Yang
Ying Chang
Ke Wang
Yang Lv
Yuanfeng Tong
Mei Gao
Guanhua Du
Song Wu
Original Assignee
Cspc Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Inst Materia Medica Cams
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cspc Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd, Inst Materia Medica Cams filed Critical Cspc Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Publication of CU20110104A7 publication Critical patent/CU20110104A7/es
Publication of CU24127B1 publication Critical patent/CU24127B1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)

Abstract

Dos formas cristalinas de pinocembrina de fórmula ): alfa y beta, su preparación y su uso para la fabricación de composiciones farmacéuticas. Existe una diferencia entre ellas en biodisponibilidad. Se usan para tratar y prevenir las enfermedades isquémicas cerebrales mediante la acción protectora de la unidad neurovascular, y aumentar el nivel de fármaco en sangre in vivo. ESPACIO PARA LA FÓRMULA
CUP2011000104A 2008-11-13 2008-11-13 DOS TIPOS DE FORMAS CRISTALINAS DE PINOCEMBRINA: alfa y beta CU24127B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2008/073047 WO2010054512A1 (zh) 2008-11-13 2008-11-13 生松素化合物的两种晶型、其制备方法及其在制备药物中的应用

Publications (2)

Publication Number Publication Date
CU20110104A7 true CU20110104A7 (es) 2012-01-31
CU24127B1 CU24127B1 (es) 2015-08-27

Family

ID=42169590

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2011000104A CU24127B1 (es) 2008-11-13 2008-11-13 DOS TIPOS DE FORMAS CRISTALINAS DE PINOCEMBRINA: alfa y beta

Country Status (17)

Country Link
US (1) US8399511B2 (es)
EP (1) EP2360152B8 (es)
JP (1) JP5608666B2 (es)
KR (1) KR101646805B1 (es)
AP (1) AP2943A (es)
AU (1) AU2008364170B2 (es)
BR (1) BRPI0823286A2 (es)
CA (1) CA2743618C (es)
CU (1) CU24127B1 (es)
EA (1) EA020224B1 (es)
ES (1) ES2476615T3 (es)
HK (1) HK1160117A1 (es)
IL (1) IL212849A0 (es)
MX (1) MX2011005024A (es)
UA (1) UA102871C2 (es)
WO (1) WO2010054512A1 (es)
ZA (1) ZA201104276B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1285334C (zh) * 2004-05-12 2006-11-22 中国医学科学院药物研究所 生松素在制备防治神经细胞损伤相关疾病药物中的应用
EP1957474A4 (en) * 2005-11-04 2011-08-24 Harvard College SYNTHESIS OF FTSZ HEMMERN
CN101307044B (zh) 2007-05-16 2012-07-04 中国医学科学院药物研究所 生松素化合物两种晶型和制备方法及在疾病治疗中的应用

Also Published As

Publication number Publication date
US8399511B2 (en) 2013-03-19
AU2008364170A1 (en) 2010-05-20
CA2743618C (en) 2016-01-26
JP2012508694A (ja) 2012-04-12
CA2743618A1 (en) 2010-05-20
AP2011005753A0 (en) 2011-06-30
HK1160117A1 (en) 2012-08-10
KR101646805B1 (ko) 2016-08-08
EA020224B1 (ru) 2014-09-30
AU2008364170B2 (en) 2014-06-26
UA102871C2 (uk) 2013-08-27
EP2360152A4 (en) 2012-05-30
AP2943A (en) 2014-07-31
ES2476615T3 (es) 2014-07-15
MX2011005024A (es) 2011-08-17
CU24127B1 (es) 2015-08-27
JP5608666B2 (ja) 2014-10-15
WO2010054512A1 (zh) 2010-05-20
ZA201104276B (en) 2012-02-29
EP2360152B1 (en) 2014-04-09
EP2360152B8 (en) 2014-06-11
IL212849A0 (en) 2011-07-31
BRPI0823286A2 (pt) 2015-06-16
EP2360152A1 (en) 2011-08-24
US20110213024A1 (en) 2011-09-01
KR20110082599A (ko) 2011-07-19
EA201170665A1 (ru) 2011-12-30

Similar Documents

Publication Publication Date Title
CL2013003598A1 (es) Compuestos derivados de benzooxazepinona, moduladores de canales de sodio; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades seleccionadas de arritmias, insuficiencia cardiaca, angina, infarto al miocardio, diabetes, entre otras
AR066130A1 (es) Formas cristalinas de saxagliptina y procesos para preparar las mismas
PE20180318A1 (es) Procedimiento para preparar isoquinolinonas y formas solidas de isoquinolinonas
CR20110353A (es) Compuestos de tiazolopiridina moduladores de sirtuina referencia cruzada
UY32455A (es) Derivados de aminotetralina, composiciones farmacéuticas que la contienen, y sus usos en terapia
UY31169A1 (es) Compuestos moduladores de sirtuinas
ECSP14006132A (es) Derivados de ácido benzotiazol-6-il acético y su uso para tratar una infección por vih
CO6741228A2 (es) Inhibidores de la neprilisina
AR073138A1 (es) Derivados de dioxa-biciclo (3.2.1) octano- 2,3,4-triol
UY30481A1 (es) Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos.
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
BR112014016165A2 (pt) compostos de benzaldeído substituído e métodos para seu uso no aumento da oxigenação do tecido
CL2011003266A1 (es) Compuestos derivados de imidazolidin-2-ona, con actividad inhibidora de 17alfa-hidroxilasa/liasa-c17,20; composicion farmaceutica que los comprende; y uso en el tratamiento de inflamacion o cancer, entre otras.
UY31198A1 (es) Amidas de ácidos benzoicos triazinil sustituidos, composiciones farmacéticas conteniéndolos y aplicaciones.
BR112015000578A2 (pt) moduladores da via do complemento e usos dos mesmos
BRPI0721905B8 (pt) composto inibidor de proteassoma, sua composição farmacêutica e seu uso
UY31189A1 (es) Compuestos heterocíclicos
CU20170144A7 (es) Compuestos de tetrahidroquinolinona sustituidos como moduladores gamma ror
UY29802A1 (es) Análogos de la feniletilamina y su uso en el tratamiento del glaucoma
UY32259A (es) Nuevos compuestos de hidroxiareno, preparados farmaceuticos que los contienen y aplicaciones
CO6511272A2 (es) Compustos de pirazol como antahonistas de crth2
BR112014014452A2 (pt) derivados de pirazolpiridina, processo de preparação dos mesmos e uso terapêutico dos mesmos
UY32673A (es) Nuevas pirimidinas, composiciones farmaceuticas que las contienen, procedimientos de preparaciones y su aplicacion como medicamentos
AR063560A1 (es) Compuestos organicos
ECSP11011503A (es) Compuestos carboxamida y su uso como inhibidores de calpaína.

Legal Events

Date Code Title Description
FG Grant of patent